1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Montserret, R.
Penin, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Virol.
JOVIAM
0825
0022-538X
83
6257
6268
10.1128/JVI.02663-08
19357161
Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B
2009
10.2210/pdb2jxf/pdb
pdb_00002jxf
3601.116
Genome polyprotein
Non-structural protein 4B, UNP residues 1751-1780
1
syn
polymer
NS4B(40-69)
no
no
QTNWQKLEVFWAKHMWNFISGIQYLAGLST
QTNWQKLEVFWAKHMWNFISGIQYLAGLST
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Data collection
Database references
Derived calculations
1
0
2008-11-25
1
1
2011-07-13
1
2
2022-03-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
BMRB
Y
PDBJ
2007-11-19
REL
REL
The peptide was synthesized by solid-phase synthesis; Free N and C termini
sample
structures with the least restraint violations
50
30
2D 1H-1H NOESY
2D 1H-1H TOCSY
2D 1H-13C HSQC
1
mM
50
%
50
%
0
6.5
ambient
298
K
DGSA-distance geometry simulated annealing
1
lowest rmsd deviation from the ensemble
1mM NS4B(40-69); 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O
50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O
Varian
collection
VNMR
Goddard
chemical shift assignment
Sparky
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR NIH
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR NIH
500
Varian
UNITYPLUS
Varian UnityPlus
GLN
1
n
1
GLN
1
A
THR
2
n
2
THR
2
A
ASN
3
n
3
ASN
3
A
TRP
4
n
4
TRP
4
A
GLN
5
n
5
GLN
5
A
LYS
6
n
6
LYS
6
A
LEU
7
n
7
LEU
7
A
GLU
8
n
8
GLU
8
A
VAL
9
n
9
VAL
9
A
PHE
10
n
10
PHE
10
A
TRP
11
n
11
TRP
11
A
ALA
12
n
12
ALA
12
A
LYS
13
n
13
LYS
13
A
HIS
14
n
14
HIS
14
A
MET
15
n
15
MET
15
A
TRP
16
n
16
TRP
16
A
ASN
17
n
17
ASN
17
A
PHE
18
n
18
PHE
18
A
ILE
19
n
19
ILE
19
A
SER
20
n
20
SER
20
A
GLY
21
n
21
GLY
21
A
ILE
22
n
22
ILE
22
A
GLN
23
n
23
GLN
23
A
TYR
24
n
24
TYR
24
A
LEU
25
n
25
LEU
25
A
ALA
26
n
26
ALA
26
A
GLY
27
n
27
GLY
27
A
LEU
28
n
28
LEU
28
A
SER
29
n
29
SER
29
A
THR
30
n
30
THR
30
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
O
H
LEU
TRP
7
11
1.59
1
A
THR
2
-154.18
-119.59
2
A
THR
2
-142.21
-105.05
2
A
LEU
28
-101.57
51.34
3
A
THR
2
-172.80
-131.67
3
A
LEU
28
-169.67
63.48
4
A
THR
2
-153.09
-52.09
4
A
ASN
3
84.55
-45.82
5
A
THR
2
-124.61
-119.92
5
A
ASN
3
58.72
6.35
5
A
LEU
28
-119.45
62.08
6
A
THR
2
-92.17
-107.44
6
A
ASN
3
66.86
-4.68
7
A
THR
2
51.95
-109.49
7
A
ASN
3
-156.37
-45.77
7
A
LEU
28
-102.42
49.62
8
A
THR
2
-139.79
-64.74
9
A
ALA
26
-86.62
45.96
9
A
LEU
28
55.28
17.82
9
A
SER
29
173.74
152.20
10
A
THR
2
66.47
-63.17
10
A
ASN
3
81.73
-50.08
10
A
SER
29
58.47
-160.90
11
A
LEU
25
-120.45
-51.06
11
A
SER
29
-161.69
-60.45
12
A
THR
2
-155.86
-119.78
12
A
SER
29
61.58
168.83
13
A
THR
2
-158.89
-116.51
13
A
ALA
26
-78.97
44.66
14
A
THR
2
-144.18
-108.97
15
A
THR
2
-109.26
-121.97
16
A
THR
2
-143.62
-100.71
16
A
SER
29
-80.59
-86.82
17
A
ASN
3
77.79
-52.62
17
A
SER
29
68.33
-64.29
18
A
THR
2
-141.92
-117.74
18
A
LEU
28
-103.95
48.95
19
A
SER
29
60.91
-160.76
20
A
LEU
28
-101.71
49.55
21
A
LEU
28
-116.54
59.32
22
A
THR
2
-101.69
-89.57
22
A
LEU
28
-98.53
45.54
23
A
THR
2
55.71
-98.85
23
A
SER
29
59.06
-165.15
24
A
THR
2
-162.39
-119.82
25
A
ALA
26
-82.59
42.37
26
A
THR
2
-161.10
-115.47
26
A
GLN
23
-92.71
44.98
26
A
TYR
24
-153.19
-54.94
27
A
ALA
26
-79.62
46.59
27
A
SER
29
-90.33
-156.25
28
A
THR
2
-165.23
-120.55
29
A
THR
2
-144.21
-115.20
30
A
THR
2
-164.90
-116.47
30
A
SER
29
62.85
-91.03
The solution structure of HCV NS4B(40-69)
1
N
N
A
THR
2
A
THR
2
HELX_P
A
LEU
28
A
LEU
28
1
1
27
VIRAL PROTEIN, MEMBRANE PROTEIN
membrane associated segment, Acetylation, Apoptosis, ATP-binding, Capsid protein, Cytoplasm, Endoplasmic reticulum, Envelope protein, Fusion protein, Glycoprotein, Helicase, Host-virus interaction, Hydrolase, Interferon antiviral system evasion, Lipid droplet, Lipoprotein, Metal-binding, Mitochondrion, Multifunctional enzyme, Nucleotide-binding, Nucleotidyltransferase, Nucleus, Oncogene, Palmitate, Phosphoprotein, Protease, Ribonucleoprotein, RNA replication, RNA-binding, RNA-directed RNA polymerase, Secreted, Serine protease, SH3-binding, Thiol protease, Transcription, Transcription regulation, Transferase, Transmembrane, Ubl conjugation, Viral nucleoprotein, Virion, Zinc, VIRAL PROTEIN, MEMBRANE PROTEIN
POLG_HCVH
UNP
1
1751
P27958
QTNWQKLEVFWAKHMWNFISGIQYLAGLST
1751
1780
2JXF
1
30
P27958
A
1
1
30